Mirion to Present at B. Riley Securities’ Radiopharma Day

ATLANTA--(BUSINESS WIRE)-- Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,700 people and operates in 12 countries. Learn more at mirion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240222117651/en/

For investor inquiries, please contact:

Jerry Estes
[email protected]

Source: Mirion

You May Also Be Interested In

• Horizon3 Earns Cyber Essentials Certification Covering NodeZero EU Network
• Thales Expands Collaboration with Google Cloud to Help Secure Agentic AI Workflows
• Eagle Plains' Partner Xcite Uranium Intersects Anomalous Radioactivity at Lorado and Commences Drill Program at the Gulch Uranium Project, Saskatchewan